Zkusit zdarma
NGM Biopharmaceuticals, Inc.

NGM Biopharmaceuticals, Inc.

NGM
Cena:
 
 
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Equity Litigation Group LLP Announces Pendency and Proposed Settlement of Stockholder Class Action for All Record Holders and Beneficial Holders of Shares of NGM Biopharmaceuticals, Inc., Common Stock

Equity Litigation Group LLP Announces Pendency and Proposed Settlement of Stockholder Class Action for All Record Holders and Beneficial Holders of Shares of NGM Biopharmaceuticals, Inc., Common Stock

10:00 08-09-2025

SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER CLASS ACTION, SETTLEMENT HEARING, ...

Quaise Energy and Nevada Gold Mines Partner on Deep Geothermal Pilot Plant to Decarbonize Mining

Quaise Energy and Nevada Gold Mines Partner on Deep Geothermal Pilot Plant to Decarbonize Mining

8:00 03-12-2024

HOUSTON--(BUSINESS WIRE)--Quaise Energy, Inc. (Quaise) and the Barrick-operated Nevada Gold Mines (N...

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

17:30 19-03-2024

SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bi...

NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates

NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates

18:31 11-03-2024

NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.33 per share versus the Zacks Cons...

Why NGM Biopharmaceuticals (NGM) Might Surprise This Earnings Season

Why NGM Biopharmaceuticals (NGM) Might Surprise This Earnings Season

10:16 07-03-2024

NGM Biopharmaceuticals (NGM) is seeing favorable earnings estimate revision activity and has a posit...

NGM Biopharmaceuticals (NGM) Reports Q3 Loss, Misses Revenue Estimates

NGM Biopharmaceuticals (NGM) Reports Q3 Loss, Misses Revenue Estimates

18:47 02-11-2023

NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.35 per share versus the Zacks Cons...

close

EQUITY LITIGATION GROUP LLP ANNOUNCES PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER CLASS ACTION FOR ALL RECORD HOLDERS AND BENEFICIAL HOLDERS OF SHARES OF NGM BIOPHARMACEUTICALS, INC., COMMON STOCK

08-09-2025
SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER CLASS ACTION, SETTLEMENT HEARING, ...
Více zde

QUAISE ENERGY AND NEVADA GOLD MINES PARTNER ON DEEP GEOTHERMAL PILOT PLANT TO DECARBONIZE MINING

03-12-2024
HOUSTON--(BUSINESS WIRE)--QUAISE ENERGY, INC. (QUAISE) AND THE BARRICK-OPERATED NEVADA GOLD MINES (N...
Více zde

NGM BIO ANNOUNCES CLOSING OF TENDER OFFER

05-04-2024
SAN FRANCISCO, APRIL 05, 2024 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (“NGM BIO”) (NASD...
Více zde

IMPORTANT INVESTOR ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

21-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 21, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

INVESTOR ACTION NOTICE: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

20-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 20, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

NGM BIO TO PRESENT TWO POSTERS HIGHLIGHTING CLINICAL DATA FROM THE ONGOING PHASE 1/2 CLINICAL TRIAL OF NGM707, A DUAL ILT2/ILT4 ANTAGONIST ANTIBODY PRODUCT CANDIDATE, AT AACR 2024 ANNUAL MEETING

19-03-2024
SOUTH SAN FRANCISCO, CALIF., MARCH 19, 2024 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NGM BI...
Více zde

IMPORTANT INVESTOR ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

19-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 19, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

IMPORTANT INVESTOR ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

18-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 18, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

INVESTOR ACTION NOTICE: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

14-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 14, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

NGM BIOPHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF NGM BIOPHARMACEUTICALS, INC. - NGM

13-03-2024
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

INVESTIGATION ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

12-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 12, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

NGM BIO PROVIDES RECENT BUSINESS HIGHLIGHTS AND REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

11-03-2024
--ENROLLMENT ONGOING FOR PATIENTS WITH MICROSATELLITE STABILITY (MSS) COLORECTAL CANCER (CRC) IN PHA...
Více zde

INVESTIGATION ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

11-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 11, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS L...
Více zde

INVESTIGATION ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

06-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 6, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LI...
Více zde

INVESTIGATION ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST NGM BIOPHARMACEUTICALS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

04-03-2024
LOS ANGELES, CA / ACCESSWIRE / MARCH 4, 2024 / THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LI...
Více zde

NGM BIOPHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF NGM BIOPHARMACEUTICALS, INC. - NGM

27-02-2024
NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ESQ. AND TH...
Více zde

NGM STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF NGM BIOPHARMACEUTICALS, INC. IS FAIR TO SHAREHOLDERS

26-02-2024
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

NGM BIO HAS ENTERED INTO A DEFINITIVE AGREEMENT AND PLAN OF MERGER WITH CERTAIN AFFILIATES OF THE COLUMN GROUP, LP

26-02-2024
SAN FRANCISCO, FEB. 26, 2024 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (“NGM BIO”) (NASDA...
Více zde

NGM BIO TO PARTICIPATE IN THE COWEN 44TH ANNUAL HEALTH CARE CONFERENCE

20-02-2024
SOUTH SAN FRANCISCO, CALIF., FEB. 20, 2024 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NASDAQ:...
Více zde

NGM BIO TO PARTICIPATE IN THE B. RILEY SECURITIES 4TH ANNUAL ONCOLOGY CONFERENCE

17-01-2024
SOUTH SAN FRANCISCO, CALIF., JAN. 17, 2024 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NASDAQ:...
Více zde

NGM BIO PRESENTS POSITIVE PHASE 2B RESULTS FROM THE ALPINE 4 TRIAL OF ALDAFERMIN IN PATIENTS WITH COMPENSATED CIRRHOSIS (F4) DUE TO NASH AT AASLD THE LIVER MEETING®

13-11-2023
--AS PREVIOUSLY REPORTED, THE ALPINE 4 STUDY MET ITS PRIMARY ENDPOINT, WITH ALDAFERMIN 3 MG DEMONSTR...
Více zde

NGM BIO REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS

02-11-2023
--JEAN-FRÉDÉRIC VIRET, PH.D., HAS BEEN APPOINTED AS CHIEF FINANCIAL OFFICER EFFECTIVE NOVEMBER 3, ...
Více zde

NGM BIO ANNOUNCES ORAL PLENARY PRESENTATION OF DATA FROM PHASE 2B ALPINE 4 TRIAL OF ALDAFERMIN IN COMPENSATED CIRRHOSIS (F4) DUE TO NASH AT UPCOMING AASLD THE LIVER MEETING®

11-10-2023
SOUTH SAN FRANCISCO, CALIF., OCT. 11, 2023 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NGM BIO...
Více zde

NGM BIO REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS HIGHLIGHTS

03-08-2023
--ANNOUNCED POSITIVE DATA FROM PHASE 2 INVESTIGATOR-SPONSORED TRIAL OF ALDAFERMIN FOR THE TREATMENT ...
Více zde

NGM BIO TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

25-05-2023
SOUTH SAN FRANCISCO, CALIF., MAY 25, 2023 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NGM BIO)...
Více zde

NGM BIO TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTH CARE CONFERENCE

01-03-2023
SOUTH SAN FRANCISCO, CALIF., MARCH 01, 2023 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NGM BI...
Více zde

NGM BIO PROVIDES BUSINESS HIGHLIGHTS AND REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS

28-02-2023
--PRESENTED PRELIMINARY FINDINGS FROM THE PHASE 1A MONOTHERAPY DOSE ESCALATION PORTION OF THE ONGOIN...
Více zde

NGM BIO TO PARTICIPATE IN THE B. RILEY SECURITIES 3RD ANNUAL ONCOLOGY CONFERENCE

12-01-2023
SOUTH SAN FRANCISCO, CALIF., JAN. 12, 2023 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NGM BIO...
Více zde

NGM BIO OUTLINES CORPORATE STRATEGY AND PROVIDES GUIDANCE ON KEY PRIORITIES

09-01-2023
SOUTH SAN FRANCISCO, CALIF., JAN. 09, 2023 (GLOBE NEWSWIRE) -- NGM BIOPHARMACEUTICALS, INC. (NGM BIO...
Více zde

NGM BIO GIVES PRESENTATION FEATURING PRECLINICAL CHARACTERIZATION OF NGM936 AT 2022 ASH ANNUAL MEETING

12-12-2022
--NGM936, A ILT3 X CD3 BISPECIFIC T CELL ENGAGER PRODUCT CANDIDATE, POTENTLY INDUCED T CELL DEPENDEN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2024-04-05 01:00:008-KStáhnout
2024-04-05 00:00:008-KStáhnout
2024-03-11 00:00:008-KStáhnout
2024-03-11 00:00:0010-KStáhnout
2024-03-10 23:00:008-KStáhnout
2024-03-10 23:00:0010-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-25 23:00:008-KStáhnout
2024-01-22 00:00:008-KStáhnout
2024-01-21 23:00:008-KStáhnout
2024-01-02 00:00:008-KStáhnout
2024-01-01 23:00:008-KStáhnout
2023-12-04 00:00:008-KStáhnout
2023-12-03 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-10-17 01:00:008-KStáhnout
2023-10-17 00:00:008-KStáhnout
2023-08-11 01:00:008-KStáhnout
2023-08-11 00:00:008-KStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 01:00:0010-QStáhnout
2023-08-03 00:00:008-KStáhnout
2023-08-03 00:00:0010-QStáhnout
2023-06-08 01:00:008-KStáhnout
2023-06-08 00:00:008-KStáhnout
2023-05-12 01:00:008-KStáhnout
2023-05-12 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-04-04 01:00:008-KStáhnout
2023-04-04 00:00:008-KStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-28 00:00:0010-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-27 23:00:0010-KStáhnout
2022-12-20 00:00:008-KStáhnout
2022-12-19 23:00:008-KStáhnout
2022-11-03 00:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:008-KStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-10-17 01:00:008-KStáhnout
2022-10-17 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-07-13 01:00:008-KStáhnout
2022-07-13 00:00:008-KStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-05-24 01:00:008-KStáhnout
2022-05-24 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-03-10 00:00:008-KStáhnout
2022-03-09 23:00:008-KStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2021-11-04 00:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:008-KStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-07-01 01:00:008-KStáhnout
2021-07-01 00:00:008-KStáhnout
2021-06-10 01:00:008-KStáhnout
2021-06-10 00:00:008-KStáhnout
2021-05-24 01:00:008-KStáhnout
2021-05-24 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-04-28 01:00:008-KStáhnout
2021-04-28 00:00:008-KStáhnout
2021-03-15 00:00:008-KStáhnout
2021-03-15 00:00:0010-KStáhnout
2021-03-14 23:00:008-KStáhnout
2021-03-14 23:00:0010-KStáhnout
2021-03-04 00:00:008-KStáhnout
2021-03-03 23:00:008-KStáhnout
2021-01-06 00:00:008-KStáhnout
2021-01-05 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-08-12 01:00:008-KStáhnout
2020-08-12 01:00:0010-QStáhnout
2020-08-12 00:00:008-KStáhnout
2020-08-12 00:00:0010-QStáhnout
2020-06-08 01:00:008-KStáhnout
2020-06-08 00:00:008-KStáhnout
2020-05-27 01:00:008-KStáhnout
2020-05-27 00:00:008-KStáhnout
2020-05-13 01:00:008-KStáhnout
2020-05-13 01:00:0010-QStáhnout
2020-05-13 00:00:008-KStáhnout
2020-05-13 00:00:0010-QStáhnout
2020-03-17 00:00:008-KStáhnout
2020-03-17 00:00:0010-KStáhnout
2020-03-16 23:00:008-KStáhnout
2020-03-16 23:00:0010-KStáhnout
2020-03-09 00:00:008-KStáhnout
2020-03-08 23:00:008-KStáhnout
2020-02-24 00:00:008-KStáhnout
2020-02-23 23:00:008-KStáhnout
2020-02-13 00:00:008-KStáhnout
2020-02-12 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-12-05 00:00:008-KStáhnout
2019-12-04 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-10-07 01:00:008-KStáhnout
2019-10-07 00:00:008-KStáhnout
2019-08-12 01:00:008-KStáhnout
2019-08-12 01:00:0010-QStáhnout
2019-08-12 00:00:008-KStáhnout
2019-08-12 00:00:0010-QStáhnout
2019-05-16 01:00:008-KStáhnout
2019-05-16 01:00:0010-QStáhnout
2019-05-16 00:00:008-KStáhnout
2019-05-16 00:00:0010-QStáhnout
2019-04-08 01:00:008-KStáhnout
2019-04-08 00:00:008-KStáhnout
preloader